![Micki Klearman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Micki Klearman worked as Associate Group Medical Director-Immunology at Genentech, Inc. from 2007 to 2018.
Dr. Klearman worked as Independent Director at Kezar Life Sciences, Inc. from 2021 to 2026.
Dr. Klearman completed undergraduate studies at Stanford University and earned a doctorate from Washington University School of Medicine.
Eerdere bekende functies van Micki Klearman
| Bedrijven | Functie | Einde |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Directeur/Bestuurslid | 11-05-2026 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Micki Klearman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
74
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
